NAD+ × Research Peptides Europe — lab test, December 2025
This lab doesn't publish a public lookup, so we can't confirm the certificate against the lab's own record. The document was reviewed before publication, but it rests on our review alone.
What portal verification means →Test results
Not on file for this certificate: sterility and heavy metals. A purity figure says nothing about those.
About this test
Label 100 mg · Lab measured 100.8 mg
101% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 25.2 mg using the measured mass, against 25 mg on the label — 1% more.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
| Report number | NAD+/2025-12-03 |
|---|---|
| Portal lookup | Lab has no portalThis laboratory publishes no public lookup, so the report cannot be confirmed independently. |
| PDF vs portal | liquilabs's portal shows validity only |
| Weight | Counts as one lab test |
Independent HPLC purity analysis of NAD+ from Research Peptides Europe, performed by liquilabs on December 29, 2025. Reported purity: 99.8%. Net content: 100.8 mg against 100 mg labeled (101% of label). Endotoxins: < 0.001 EU/mg. Batch NAD+/2025-12-03. Sample source: shop-provided. Certificate of analysis attached.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion